CCRB Logo

Trial History Detail on 2015-06-18

CUHK_CCT00375

2013-07-24

Prospective

CRE-2013.358-T

Nil/ a self funded study

Dr. CHEUNG Lap Kei, the principal investigator, who is a resident in the Department of Psychiatry, Tai Po Hospital

N/A

Dr. CHEUNG LAP KEI

Department of Psychiatry, Tai Po Hospital, 9 Chuen On Road, Tai Po, Hong Kong

26076111

clk965@ha.org.hk

Tai Po Hospital

Dr. CHEUNG LAP KEI

Department of Psychiatry, Tai Po Hospital, 9 Chuen On Road, Tai Po, Hong Kong

26076111

clk965@ha.org.hk

Tai Po Hospital

A controlled study of the benefits of an aerobic exercise programme in psychiatric outpatients on treatment for depression in Hong Kong

A study on aerobic exercise as treatment for depression

運動對治療抑鬱症之學術研究

A study on aerobic exercise as adjunct treatment for depression

Hong Kong

Yes

2013-07-18

Depression

Behavior

An aerobic exercise programme consists of jogging, fast walking and cycling, as adjunct treatment to treatment as usual

12 weeks

Treatment as usual in the psychiatric outpatient clinics

patients with major depressive disorder as diagnosed by the Structured Clinical Interview for DSM-IV with the Hamilton Depression Rating Scale score >= 14 and self reported to be physically inactive at the time of the study (with <2 times of exercise per week)

Patients will be excluded if they are 1) suffering from depressive symptoms in other mental illnesses e.g. bipolar affective disorder, psychotic disorders including schizophrenia and schizoaffective disorder, and obsessive-compulsive disorder, 2) taking substance(s), and 3) suffering from physical conditions that prevent them from doing jogging, cycling or brisk walking. These conditions include untreated hypertension, ischaemic heart disease, cardiomyopathy, arrhythmia, moderate to severe respiratory diseases, history of cerebrovascular accident, severe liver and renal problems, musculoskeletal conditions that hinder the patients from doing aerobic exercise, and any other physical condition or severity of a physical condition that in the opinion of the patient’s physician or the principal investigator that the patient is unfit to participate in the exercise programme. And for women, patients who are currently pregnant or who plan to get pregnant in the next 3 months will also be excluded.

18

65

Both Male and Female

Interventional

Randomized

Placebo

Single-blind

Parallel

2013-08-15

60

Unknown

Depression severity to be measured at baseline and 12 weeks by Hamilton Depression Rating Scale.

Secondary outcome measures will assess somatic distress (by PHQ-15), anxiety (by STAI), quality of life (by SF-36), sleep quality (by Pittsburg Sleep Quality Index), certain cognitive performance (the Trail-making test, the Hong Kong List Learning Test, and the verbal fluency test) and body composition (body weight and waist circumference). All measures will be performed at baseline and 12 weeks after randomization.
For the intervention group, the Hospital Anxiety and Depression Scale and PHQ-15 will be administered weekly during the intervention session.

No

2015-06-18

ChiCTR-TRC-13003358


Yes

Type Access Document Published On  
No documents yet.
  • Page 1 of 1.